271980.KS KSC
Jeil Pharmaceutical Co.,Ltd
1W: +0.3%
1M: -12.4%
3M: -1.3%
YTD: -32.1%
1Y: -28.1%
3Y: -46.1%
5Y: -76.9%
₩10,000.00 ($7.43)
-30.00 (-0.30%)
Weekly Expected Move ±1.7%
₩9666
₩9833
₩10000
₩10167
₩10334
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩147.0B ($109.3M)
52W Range8810-19290
Volume7,704
Avg Volume57,479
Beta1.53
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSeok-Jae Sung
Employees973
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2017-07-18
Websitejeilpharm.co.kr
343, Sapyeong-daero
Seoul, SL 06543
KR
Seoul, SL 06543
KR
82 2 549 7451
About Jeil Pharmaceutical Co.,Ltd
Primarily active within South Korea, Jeil Pharmaceutical Co.,Ltd dedicates itself to the development and supply of a broad spectrum of pharmaceutical goods. Its product offerings address numerous therapeutic categories, including antibiotics, gastrointestinal health, cardiovascular conditions, neuropsychiatric disorders, cancer (oncology), endocrine imbalances, urological issues, viral infections, and antihistamine remedies. Furthermore, the company extends its market reach globally, exporting its merchandise to roughly 40 nations across the ASEAN bloc, Central and South America, Africa, and other international destinations. Founded in 1959, Jeil Pharmaceutical Co.,Ltd maintains its headquarters in Seoul, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found